Flotek Industries Inc (FTK) stock analysis
Close on Nov 11, 2026Market cap $957.31MP/E 33.0Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed11 of 30 checks passed
Flotek Industries passes 11 of the 30 checks behind our score; 12 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 3/6
- Past performance
- 4/6
- Financial health
- 3/6
- Dividend
- 0/6
What stands out
Return on capital over 10%
Return on invested capital was 30.8%, above the 10% that usually covers the cost of capital.
Revenue growing 10%+ a year
Revenue grew 20.4% a year over the last three fiscal years.
Interest well covered
Operating income covers interest expense 8.5 times.
Low bankruptcy risk
The Altman Z-score is 4.35; above 3 is the safe zone and below 1.8 the distress zone.
What to watch
Margin of safety under 20%
The price is 20.8% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $26.43 is above our fair value estimate of $21.88.
Return on equity under 15%
Return on equity was 24.4% over the last twelve months and averaged -75.6% over five years; we look for 15% on both.
P/E above the industry
Flotek Industries's P/E of 33.0 is above the Chemicals and Allied Products median of 25.2.
Valuation1/6
P/E against its history
Not enough price and earnings history to compare.
P/E above the industry
Flotek Industries's P/E of 33.0 is above the Chemicals and Allied Products median of 25.2.
EV/EBITDA below its 5-year median
Flotek Industries's EV/EBITDA of 20.2 is below its 5-year median of 22.6.
P/B above the industry
Flotek Industries's price-to-book of 6.67 is above the Chemicals and Allied Products median of 2.24.
Trading above fair value
The share price of $26.43 is above our fair value estimate of $21.88.
Margin of safety under 20%
The price is 20.8% above fair value, so there is no margin of safety.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 20.4% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 59.3% over the last twelve months; the Chemicals and Allied Products median is 11.0%.
Guidance raised
Flotek Industries raised its 2026 Total Revenues outlook on Aug 4, 2026.
Gross margin slipping
Gross margin was 23.3% over the last twelve months, against 25.8% a year earlier.
Past performance4/6
Return on equity under 15%
Return on equity was 24.4% over the last twelve months and averaged -75.6% over five years; we look for 15% on both.
Return on capital over 10%
Return on invested capital was 30.8%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Flotek Industries's return on equity of 24.4% is above the Chemicals and Allied Products median of 7.4%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 8.8% over the last twelve months, against a 5-year average of -14.0%.
Net margin above the industry
Flotek Industries's net margin of 8.8% is above the Chemicals and Allied Products median of 5.6%.
Financial health3/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest well covered
Operating income covers interest expense 8.5 times.
Short-term assets cover short-term debts
Current assets are 2.30 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 4.35; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Flotek Industries has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$21.88
The share price is 21% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 25.2× | – | 25.2× | $20.18 | 47% |
| EV/EBITDA | 20.7× | 22.6× | 18.8× | $27.14 | 41% |
| P/B | 2.6× | 3.0× | 2.2× | $10.31 | 12% |
| Fair value | $21.88 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Chemicals and Allied Products median 25.2
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $9.67M
- Value traded per 1% price move
- $2.80M
Downside
High risk
- Typical loss in a bad month
- 27.9%
- Volatility (annualized)
- 76%
- Sharpe ratio, 1 year
- 0.91
- Beta to the S&P 500 (5Y)
- 1.20
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +26.9% | +20.4% | +34.9% | -1.3% | |
| Gross profit | +51.9% | – | – | -4.6% | |
| Operating income | +90.6% | – | – | +6.6% | |
| Net income | +190.8% | – | – | – | |
| EPS, diluted | +147.1% | – | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -16.9% | -124.5% | 26.9% | |
| Return on assets | -12.5% | -86.1% | 15.6% | |
| Current ratio | 2.15 | 2.30 | 1.80 | |
| Debt to equity | 0.17 | 0.12 | – | |
| Net debt to EBITDA | -4.95× | 0.24× | – | |
| Interest coverage | -8.6× | -2394.1× | 5.9× | |
| Inventory turnover | 1.8× | 4.7× | 14.8× | |
| Capex to revenue | 6.9% | 2.7% | – | |
| Diluted shares | 9M | 11M | 36M |
Cash use needs five years of cash flow figures
Flotek Industries does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 12.9% | 1.21× | 1.72× | 26.9% |
| FY2024 | 5.6% | 1.14× | 1.52× | 9.7% |
| FY2023 | 13.1% | 1.17× | 3.08× | 47.3% |
| FY2022 | -31.1% | 1.27× | 9.44× | -371.3% |
| FY2021 | -70.6% | 0.63× | 2.03× | -90.6% |
| FY2020 | -256.8% | 0.34× | 1.45× | -124.5% |
| FY2019 | -28.4% | 0.46× | 1.38× | -18.1% |
| FY2018 | -39.6% | 0.58× | 1.32× | -30.1% |
| FY2017 | -11.3% | 0.68× | 1.29× | -9.9% |
| FY2016 | -26.1% | 0.48× | 1.35× | -16.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$30.53M
- Cash generatingOperating cash flow above zero$7.20M
- Return on assets improvedROA up on the prior year6.7% → 17.9%
- Earnings backed by cashOperating cash flow above net income$7.20M vs $30.53M
- Less leverageLong-term debt to assets fell0.0% → –
- Better liquidityCurrent ratio rose1.92 → 1.80
- No dilutionShare count did not rise31M → 36M
- Gross margin improvedGross margin up on the prior year21.06% → 25.22%
- More efficientAsset turnover rose1.19 → 1.39
See a number that looks wrong?